INDRAPRASTHA MEDICAL CORP.
Indraprastha Medical Corporation Limited is an Indiabasedspecialty carecompany engaged in healthcare business. The company provides diagnostic, medical, and surgical facilitiesto its patients. Itprovides various surgery services, including gastroenterology and GI, cardiothoracic, and others.
On the financial front, Indraprastha Medical Corporation posted 4.80 per cent decline in its net sales to ₹184.24 crore in the first quarter of FY18, as against ₹193.53 crore in the same quarter of the previous fiscal. The company’s PBIDT declined by 20.95 per cent to ₹16.91 crore in Q1FY18 as compared to ₹21.39 crore in the same quarter of the previous fiscal. The profit after tax of the company decreased by 41.84 per cent to ₹4.76 crore in the first quarter of FY18 as against ₹8.19 crore in the same quarter of the previous fiscal. On an annual basis, the company’s net sales dropped by 0.47 per cent to ₹729 crore in FY2017 on a year-onyear basis. The company’s PBIDT declined by 2.17 per cent to ₹77.66 crore in FY17 as against ₹79.38 crore in the previous fiscal. However, the company’s profit after tax increased by 7.45 per cent to ₹26.25 crore in FY2017 as against ₹24.45 crore in the previous fiscalyear. The stock has a strong growth momentum. We recommend the reader-investors to Hold the stock.